Description
MyHep All Tablet
Brand Name : MyHep All Tablet
Contents : Velpatasvir and Sofosbuvir
Marketed by : MyLan Pharmaceutical
Strength : Velpatasvir 100mg and Sofosbuvir 400 mg
Packing : Pack of 28 tablets
Shipping: Worldwide
MyHep All Tablet: Effective Treatment for Hepatitis C
Myhep All Tablet treats chronic hepatitis C virus (HCV) infection effectively. It combines two active ingredients: Sofosbuvir (400 mg) and Velpatasvir (100 mg). Together, these ingredients target multiple HCV genotypes and improve treatment outcomes.
Uses
- Treat chronic hepatitis C in adults.
- Suitable for patients with HCV genotypes 1, 2, 3, 4, 5, or 6, including those with compensated cirrhosis (Child-Pugh A).
- Used as part of a combination regimen, with or without ribavirin, depending on the genotype and patient needs.
Dosage and Administration
Take one tablet orally once daily, with or without food. The treatment duration depends on your specific HCV genotype and overall health. Follow your healthcare provider’s instructions carefully to ensure effective results.
Storage Instructions
- Store at room temperature, between 20°C to 25°C (68°F to 77°F).
- Keep it in a dry place, away from moisture and heat.
- Ensure it is out of reach of children and pets.
Side Effects
Common side effects include:
- Fatigue
- Headache
- Nausea
- Diarrhea
- Insomnia
- Rash
- Muscle or joint pain
- Decreased appetite
If you experience severe or persistent side effects, contact your healthcare provider immediately.
Why Choose MyHep All?
This treatment offers an advanced solution for chronic hepatitis C. With its powerful combination of Sofosbuvir and Velpatasvir, it provides comprehensive coverage for various genotypes. By adhering to your healthcare provider’s guidance, you can achieve better health and manage HCV effectively.
Myhep All Tablet Price: Oddway International offers MyHep All Tablet at competitive prices, making it an accessible choice for patients seeking effective hepatitis C treatment. Combining Sofosbuvir (400 mg) and Velpatasvir (100 mg), this advanced medication targets multiple HCV genotypes.
Reviews
There are no reviews yet.